Found: 23
Select item for more details and to access through your institution.
Stronger association of intact angiotensinogen with mortality than lactate or renin in critical illness: post-hoc analysis from the VICTAS trial.
- Published in:
- Critical Care, 2024, v. 28, n. 1, p. 1, doi. 10.1186/s13054-024-05120-w
- By:
- Publication type:
- Article
Angiotensin II treatment is associated with improved oxygenation in ARDS patients with refractory vasodilatory shock.
- Published in:
- Annals of Intensive Care, 2023, v. 13, n. 1, p. 1, doi. 10.1186/s13613-023-01227-5
- By:
- Publication type:
- Article
The Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) Protocol: a prospective, multi-center, double-blind, adaptive sample size, randomized, placebo-controlled, clinical trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Angiotensin II for Vasodilatory Hypotension in Patients Requiring Mechanical Circulatory Support.
- Published in:
- Journal of Intensive Care Medicine, 2023, v. 38, n. 5, p. 464, doi. 10.1177/08850666221145864
- By:
- Publication type:
- Article
Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Rethinking Vasopressor Education: The Need to Avoid Teaching the Bare Minimum.
- Published in:
- ATS Scholar, 2023, v. 4, n. 3, p. 389, doi. 10.34197/ats-scholar.2023-0030LE
- By:
- Publication type:
- Article
Angiotensin II for the treatment of distributive shock in the intensive care unit: A US cost-effectiveness analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor–Biased Ligand in Adults With COVID-19: Two Randomized Clinical Trials.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 329, n. 14, p. 1170, doi. 10.1001/jama.2023.3546
- By:
- Publication type:
- Article
COVID-19 and the RAAS-a potential role for angiotensin II?
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Effect of Vitamin C, Thiamine, and Hydrocortisone on Ventilator- and Vasopressor-Free Days in Patients With Sepsis: The VICTAS Randomized Clinical Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trial.
- Published in:
- Critical Care, 2023, v. 27, n. 1, p. 1, doi. 10.1186/s13054-023-04446-1
- By:
- Publication type:
- Article
Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021–August 2022.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, n. 4, p. 547, doi. 10.1093/cid/ciad276
- By:
- Publication type:
- Article
The use of angiotensin II in distributive shock.
- Published in:
- 2016
- By:
- Publication type:
- journal article
In response: Letter on update to the Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) protocol.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Update to the Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) protocol: statistical analysis plan for a prospective, multicenter, double-blind, adaptive sample size, randomized, placebo-controlled, clinical trial.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Ascertainment of vaccination status by self‐report versus source documentation: Impact on measuring COVID‐19 vaccine effectiveness.
- Published in:
- Influenza & Other Respiratory Viruses, 2022, v. 16, n. 6, p. 1101, doi. 10.1111/irv.13023
- By:
- Publication type:
- Article
Total and Subgenomic RNA Viral Load in Patients Infected With SARS-CoV-2 Alpha, Delta, and Omicron Variants.
- Published in:
- Journal of Infectious Diseases, 2023, v. 228, n. 3, p. 235, doi. 10.1093/infdis/jiad061
- By:
- Publication type:
- Article
Sensitivity to angiotensin II dose in patients with vasodilatory shock: a prespecified analysis of the ATHOS-3 trial.
- Published in:
- Annals of Intensive Care, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1186/s13613-019-0536-5
- By:
- Publication type:
- Article
Angiotensin II: a new therapeutic option for vasodilatory shock.
- Published in:
- Therapeutics & Clinical Risk Management, 2018, v. 14, p. 1287, doi. 10.2147/TCRM.S150434
- By:
- Publication type:
- Article
Angiotensin in Critical Care.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The effect of angiotensin II on blood pressure in patients with circulatory shock: a structured review of the literature.
- Published in:
- 2017
- By:
- Publication type:
- journal article